0
Your cart

Your cart is empty

Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology

Buy Now

Methodologies in Biosimilar Product Development (Hardcover) Loot Price: R5,444
Discovery Miles 54 440
Methodologies in Biosimilar Product Development (Hardcover): Sangjoon Lee, Shein-Chung Chow

Methodologies in Biosimilar Product Development (Hardcover)

Sangjoon Lee, Shein-Chung Chow

Series: Chapman & Hall/CRC Biostatistics Series

 (sign in to rate)
Loot Price R5,444 Discovery Miles 54 440 | Repayment Terms: R510 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Donate to Against Period Poverty

Methodologies for Biosimilar Product Development covers the practical and challenging issues that are commonly encountered during the development, review, and approval of a proposed biosimilar product. These practical and challenging issues include, but are not limited to the mix-up use of interval hypotheses testing (i.e., the use of TOST) and confidence interval approach, a risk/benefit assessment for non-inferiority/similarity margin, PK/PD bridging studies with multiple references, the detection of possible reference product change over time, design and analysis of biosimilar switching studies, the assessment of sensitivity index for assessment of extrapolation across indications without collecting data from those indications not under study, and the feasibility and validation of non-medical switch post-approval. Key Features: Reviews withdrawn draft guidance on analytical similarity assessment. Evaluates various methods for analytical similarity evaluation based on FDA's current guidelines. Provides a general approach for the use of n-of-1 trial design for assessment of interchangeability. Discusses the feasibility and validity of the non-medical switch studies. Provides innovative thinking for detection of possible reference product change over time. This book embraces innovative thinking of design and analysis for biosimilar studies, which are required for review and approval of biosimilar regulatory submissions.

General

Imprint: Crc Press
Country of origin: United Kingdom
Series: Chapman & Hall/CRC Biostatistics Series
Release date: September 2021
First published: 2022
Editors: Sangjoon Lee • Shein-Chung Chow
Dimensions: 234 x 156mm (L x W)
Format: Hardcover
Pages: 380
ISBN-13: 978-0-367-89634-8
Categories: Books > Science & Mathematics > Mathematics > Probability & statistics
Books > Science & Mathematics > Biology, life sciences > General
Books > Medicine > General issues > Medical equipment & techniques > Medical research
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN: 0-367-89634-6
Barcode: 9780367896348

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners